Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone/ethinyl estradiol and drospirenone/ethinyl estradiol

Background: Deep vein thrombosis (DVT) has been reported as an adverse event for patients receiving combined oral contraceptives. Norethindrone/ethinyl estradiol (NET/EE) and drospirenone/ethinyl estradiol (DRSP/EE) are two commonly prescribed combined hormonal oral contraceptive agents used in the...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Jennifer Stalas, Robert Morris, Kun Bu, Kevin von Bargen, Rebekah Largmann, Kathryn Sanford, Jacob Vandeventer, Weiru Han, Feng Cheng
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2024-03-01
Rangatū:	Heliyon
Ngā marau:	FAERS DVT DRSP Pharmacovigilance Drug-drug interactions DDI
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2405844024024939
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!